FMP
May 16, 2024 8:09 PM - Davit Kirakosyan(Last modified: May 17, 2024 2:05 AM)
ZimVie (NASDAQ:ZIMV) shares rose around 2% intra-day today after Needham analysts upgraded the company to Buy from Hold, setting a price target of $20 on the stock.
The analysts explained that channel checks and market commentary indicate the implant market remained stable into the second quarter of 2024. In the short term, cost reduction initiatives are expected to improve margins, even in a flat market.
ZimVie has gained more customers year-over-year, positioning it well for when demand returns, which could further expand margins. The benchmarking analysis suggests that ZimVie has significant long-term margin improvement potential. Considering these factors and the attractive valuation, the analysts believe ZimVie's risk/reward profile is favorable.
Oct 31, 2023 8:03 AM - Parth Sanghvi
Free cash flow to the firm (FCFF) and free cash flow to equity (FCFE) are two of the most important metrics used in financial modeling. Both metrics measure the amount of cash that is available to a company's shareholders and creditors, but there is a key difference between the two. FCFF measures...
Nov 25, 2023 6:39 AM - Parth Sanghvi
Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...
Dec 23, 2023 2:19 AM - Parth Sanghvi
Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...